- Headquarters
- Providence
- Employees
- 11–50
- Founded
- 2005
- Business Model
- B2B
- Website
- nabsys.com
- Total Funding
- $10.0M
- Last Round
- $10.0M Venture RoundSep 2011
- Rounds
- 1
About
Nabsys is the pioneer of electronic genome mapping (EGM), using solid-state nanodetectors to survey long DNA molecules and construct high-density genomic maps. Founded in 2005 as a merger of two Brown University startups in Providence, Rhode Island, Nabsys developed proprietary nanodetection technology that eliminates optical components from traditional genome mapping, yielding higher resolution detection of structural variants ranging from 300bp to large chromosomal rearrangements. Its OhmX Platform enables human whole-genome mapping at scale, with strategic support from Hitachi High-Tech.
Summary
NABsys is a Biotech company based in Providence, United States, founded in 2005. It has raised $10.0M in total across 1 round, most recently a $10.0M Venture Round round in Sep 2011.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2011
Similar Companies
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...